Clarus Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Clarus Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,973	Closed	-$584K	–	113
2021 Q1	$584K	Hold	8,973	–	–	0.37%	54
2020 Q4	$561K	Hold	8,973	–	–	0.37%	50
2020 Q3	$561K	Hold	8,973	–	–	0.43%	50
2020 Q2	$686K	Hold	8,973	–	–	0.58%	35
2020 Q1	$702K	Hold	8,973	–	–	0.7%	35
2019 Q4	$591K	Hold	8,973	–	–	0.39%	70
2019 Q3	$569K	Buy	+8,973	New	+$587K	0.42%	55
2018 Q4	–	Sell	-53	Closed	-$4K	–	687
2018 Q3	$4K	Buy	53 +1	+2%	+$76	﹤0.01%	631
2018 Q2	$4K	Buy	+52	New	+$3.67K	﹤0.01%	645

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Clarus Wealth Advisors's GILD Position: Q2 2021 in Review

Clarus Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 8,973 shares — an estimated $584K sold.

Clarus Wealth Advisors first reported a position in GILD in Q2 2018 and held it in 9 quarters. The position peaked at $702K in Q1 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

Clarus Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
Clarus Wealth Advisors sold 8,973 Gilead Sciences shares in Q2 2021, an estimated $584K.
Clarus Wealth Advisors first reported a position in Gilead Sciences in Q2 2018 and held it in 9 quarters.
Clarus Wealth Advisors's Gilead Sciences position peaked at $702K in Q1 2020.
1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Clarus Wealth Advisors's 13F filing for Q2 2021, filed 13 Jul 2021.